Is this the best you can do, vrs37? Surely there muse be...

Is this the best you can do, vrs37? Surely there muse be something about today's announcement that you can criticize?

As for NOXCOVID, I think your dismissive 'guess' demonstrates an inability to read the room. NOX continues to identify Septic Shock as a major opportunity, which it might not do if the cytokine and clinical data from NOXCOVID provided unconvincing proof-of-concept.

I deliberately did not say the data might be used to justify a larger COVID trial. If the NOXCOVID data show a correlation between clinical response and NOX66-controlled cytokine levels, my hope is the next step will be a larger trial against SEPTIC SHOCK.